Skip to the main content
The Crier

Preclinical Research and specialist toxicology services and portfolio of drug-development products

Your saved contracts

What the buyer wrote

To provide a comprehensive, integrated portfolio of drug-development products and services, preclinical research and toxicology studies to support ongoing research for anticancer compound CADD522.

Bid for this and lost? There is a short window in which the decision can be questioned.

Details

What the buyer calls it
Preclinical Research and specialist toxicology services and portfolio of drug-development products
How they are buying
The buyer did not say
Where
in the East of England

Who the buyer named

Jean Miller was the named contact on this notice.

j.miller@uea.ac.uk